Status:
COMPLETED
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-6950 in Healthy Adult Subjects
Lead Sponsor:
Ono Pharma USA Inc
Conditions:
Healthy Adult Subjects
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
The primary objective of this study is to evaluate the safety and tolerability of ONO-6950 across ascending multiple doses in healthy adult male and female subjects. The secondary objectives are to ch...
Eligibility Criteria
Inclusion
- Healthy non-smoking male or female subjects (18-55 inclusive)
- Body mass index (BMI)of 10-35 kg/m2 (inclusive)
- For females; postmenopausal, non-lactating, and non-pregnant
Exclusion
- History or presence of clinical significant disease
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT01405651
Start Date
July 1 2011
Last Update
June 14 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Miramar Clinical Site
Miramar, Florida, United States, 33025